These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25646389)

  • 1. Corporate coalitions and policy making in the European Union: how and why British American Tobacco promoted "Better Regulation".
    Smith KE; Fooks G; Gilmore AB; Collin J; Weishaar H
    J Health Polit Policy Law; 2015 Apr; 40(2):325-72. PubMed ID: 25646389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "The law was actually drafted by us but the Government is to be congratulated on its wise actions": British American Tobacco and public policy in Kenya.
    Patel P; Collin J; Gilmore AB
    Tob Control; 2007 Feb; 16(1):e1. PubMed ID: 17297056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the influence of the tobacco industry on EU governance: automated content analysis of the EU Tobacco Products Directive.
    Costa H; Gilmore AB; Peeters S; McKee M; Stuckler D
    Tob Control; 2014 Nov; 23(6):473-8. PubMed ID: 25124165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Our reach is wide by any corporate standard": how the tobacco industry helped defeat the Clinton health plan and why it matters now.
    Tesler LE; Malone RE
    Am J Public Health; 2010 Jul; 100(7):1174-88. PubMed ID: 20466958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best of enemies: Using social network analysis to explore a policy network in European smoke-free policy.
    Weishaar H; Amos A; Collin J
    Soc Sci Med; 2015 May; 133():85-92. PubMed ID: 25863723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.
    Hawkins B; Holden C
    Global Health; 2018 Aug; 14(1):79. PubMed ID: 30071862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the treaty basis on health policy legislation in the European Union: a case study on the tobacco advertising directive.
    Boessen S; Maarse H
    BMC Health Serv Res; 2008 Apr; 8():77. PubMed ID: 18397520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atlas network: a "strategic ally" of the tobacco industry.
    Smith J; Thompson S; Lee K
    Int J Health Plann Manage; 2017 Oct; 32(4):433-448. PubMed ID: 27125556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry actors, think tanks, and alcohol policy in the United kingdom.
    Hawkins B; McCambridge J
    Am J Public Health; 2014 Aug; 104(8):1363-9. PubMed ID: 24922137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vested interests in addiction research and policy. Why do we not see the corporate interests of the alcohol industry as clearly as we see those of the tobacco industry?
    Casswell S
    Addiction; 2013 Apr; 108(4):680-5. PubMed ID: 23496067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vested interests in addiction research and policy. The challenge corporate lobbying poses to reducing society's alcohol problems: insights from UK evidence on minimum unit pricing.
    McCambridge J; Hawkins B; Holden C
    Addiction; 2014 Feb; 109(2):199-205. PubMed ID: 24261642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peer, professional, and public: an analysis of the drugs policy advocacy community in Europe.
    O'Gorman A; Quigley E; Zobel F; Moore K
    Int J Drug Policy; 2014 Sep; 25(5):1001-8. PubMed ID: 24974366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The devil is in the detail: tobacco industry political influence in the Dutch implementation of the 2001 EU Tobacco Products Directive.
    Lie JL; Willemsen MC; de Vries NK; Fooks G
    Tob Control; 2016 Sep; 25(5):545-50. PubMed ID: 26349910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the Advocacy Coalition Framework to understand EU pharmaceutical policy.
    Brooks E
    Eur J Public Health; 2018 Nov; 28(suppl_3):11-14. PubMed ID: 30383259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'A preferred consultant and partner to the Royal Government, NGOs, and the community': British American Tobacco's access to policy-makers in Cambodia.
    MacKenzie R; Collin J
    Glob Public Health; 2017 Apr; 12(4):432-448. PubMed ID: 27079136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legalism and tobacco control in the EU.
    Jarman H
    Eur J Public Health; 2018 Nov; 28(suppl_3):26-29. PubMed ID: 30383253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. British American Tobacco's partnership with Earthwatch Europe and its implications for public health.
    McDaniel PA; Malone RE
    Glob Public Health; 2012; 7(1):14-28. PubMed ID: 21347934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco control policy development in the European Union: do political factors matter?
    Bosdriesz JR; Willemsen MC; Stronks K; Kunst AE
    Eur J Public Health; 2015 Apr; 25(2):190-4. PubMed ID: 25519428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.